News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171,471 Results
Type
Article (8898)
Company Profile (90)
Press Release (162483)
Section
Business (51127)
Career Advice (218)
Deals (7587)
Drug Delivery (20)
Drug Development (28230)
Employer Resources (19)
FDA (3171)
Job Trends (4003)
News (88406)
Policy (5907)
Tag
Academia (513)
Alliances (14207)
Alzheimer's disease (333)
Antibody-drug conjugate (ADC) (79)
Approvals (3183)
Artificial intelligence (59)
Bankruptcy (45)
Best Places to Work (3428)
Biotechnology (87)
Breast cancer (125)
Cancer (992)
Career advice (204)
CAR-T (62)
Cell therapy (184)
Clinical research (22655)
Collaboration (285)
Compensation (87)
COVID-19 (770)
C-suite (86)
Cystic fibrosis (74)
Data (713)
Diabetes (51)
Diagnostics (1354)
Drug discovery (52)
Earnings (16458)
Events (30537)
Executive appointments (236)
FDA (3460)
Funding (224)
Gene therapy (90)
GLP-1 (152)
Government (704)
Healthcare (3142)
Infectious disease (809)
Inflammatory bowel disease (53)
IPO (3710)
Job creations (785)
Job search strategy (193)
Layoffs (82)
Legal (903)
Lung cancer (277)
Lymphoma (58)
Manufacturing (81)
Medical device (1002)
Medtech (1002)
Mergers & acquisitions (4045)
Metabolic disorders (116)
Neuroscience (456)
NextGen: Class of 2025 (1107)
Non-profit (658)
Northern California (831)
Obesity (57)
Opinion (50)
Patents (52)
People (18137)
Phase I (8277)
Phase II (10518)
Phase III (6603)
Pipeline (325)
Postmarket research (526)
Preclinical (3501)
Press Release (51)
Radiopharmaceuticals (79)
Rare diseases (138)
Real estate (1554)
Regulatory (4812)
Research institute (606)
Series A (36)
Southern California (731)
Startups (1139)
United States (6585)
Vaccines (147)
Date
Today (28)
Last 7 days (279)
Last 30 days (870)
Last 365 days (11856)
2025 (1774)
2024 (12093)
2023 (13232)
2022 (16355)
2021 (17026)
2020 (14083)
2019 (9388)
2018 (7386)
2017 (8306)
2016 (7749)
2015 (8882)
2014 (6522)
2013 (5248)
2012 (5494)
2011 (6089)
2010 (5678)
Location
Africa (166)
Asia (11733)
Australia (2449)
California (1880)
Canada (593)
China (176)
Colorado (42)
Connecticut (88)
Delaware (46)
Europe (24556)
Florida (179)
Illinois (147)
Indiana (91)
Japan (43)
Maryland (248)
Massachusetts (1381)
Michigan (67)
Minnesota (97)
New Jersey (518)
New York (493)
North Carolina (325)
Northern California (831)
Ohio (40)
Pennsylvania (386)
South America (233)
Southern California (731)
Texas (258)
Washington State (323)
171,471 Results for "lung biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Small Cell Lung Cancer Market Size to Reach USD 23.0 Billion by 2035, Impelled by Improved Early Diagnosis & Biomarker Research
Small Cell Lung Cancer Market Outlook 2025-2035:
February 17, 2025
·
9 min read
Press Releases
MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer
February 26, 2025
·
6 min read
Press Releases
MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients
February 27, 2025
·
4 min read
Press Releases
MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer
February 4, 2025
·
6 min read
Press Releases
MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer
December 3, 2024
·
6 min read
Drug Development
Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the initiation of its ALISertib in CAncer (ALISCA-Lung1) Phase II trial (PUMA-ALI-4201; NCT06095505) of alisertib monotherapy for the treatment of patients with extensive stage small cell lung cancer.
February 13, 2024
·
4 min read
Biotech Beach
Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the presentation of alisertib for the treatment of patients with advanced osimertinib-resistant epidermal growth factor receptor-mutated (EGFR-mutated) non-small cell lung cancer (NCT04085315) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting currently being held in Chicago.
June 3, 2024
·
6 min read
Drug Development
MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
MAIA Biotechnology, Inc. today announced new efficacy data from its Phase 2 THIO-101 clinical trial evaluating THIO sequenced with the immune checkpoint inhibitor (CPI) cemiplimab (Libtayo®) in patients with advanced non-small cell lung cancer (NSCLC) who failed 2 or more standard-of-care therapy regimens.
June 4, 2024
·
7 min read
Press Releases
Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer
February 25, 2025
·
5 min read
Lone Star Bio
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
bioAffinity Technologies, Inc., a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, reported 139% growth in the number of pulmonology practices and physicians offering CyPath® Lung to patients since Jan. 1, 2024.
June 12, 2024
·
6 min read
1 of 17,148
Next
